Literature DB >> 17390142

Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines.

Ivana Grivicich1, Andréa Regner, Caroline Zanoni, Larissa Procópio Correa, Geraldo Pereira Jotz, João Antônio Pêgas Henriques, Gilberto Schwartsmann, Adriana Brondani da Rocha.   

Abstract

BACKGROUND AND AIMS: Colorectal cancer is a common disease with high rate of mortality. Although there is evidence of some benefits of 5-fluorouracil (5-FU), the most commonly used drug in colon cancer therapy, it still remains unsatisfactory because of intrinsic or acquired drug resistance. Heat shock proteins (Hsps) synthesis can be increased by cellular insults, such as chemotherapy-induced damage. Inducible Hsp70 has been suggested to be involved in cytoprotection against apoptosis. In the present study, we investigated whether the content of Hsp70 is associated to 5-FU resistance.
METHODS: HT-29 and SNU-C4 human colon cancer cell lines were treated with 5-FU and their relative chemoresistance, and Hsp70 were determined.
RESULTS: Comparison of IC(50) values showed that the HT-29 cells were relatively resistant to 5-FU, whereas the SNU-C4 cells presented greater sensitivity to this drug. Further, 5-FU treatment leads to a hypodiploid population in HT-29 cells significantly lower compared to SNU-C4 cells. In the HT-29 cell line, 5-FU treatment promoted an increase of 5.5 times in Hsp70 concentration after 12 h. Then, within 24 h, the increase in Hsp70 levels was still about two times. In contrast, in the SNU-C4 cell line, 5-FU induced an increase of about two times in the Hsp70 content after 12 h and, after 24 h, did not significantly affect Hsp70 content.
CONCLUSIONS: These data suggest that 5-FU induced Hsp70 synthesis in the HT-29 resistant cell line and that this Hsp70 accumulation could protect against 5-FU-induced apoptosis. Thus, Hsp70 protection against 5-FU-induced apoptosis might underlie colon cancer chemoresistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390142     DOI: 10.1007/s00384-007-0307-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  58 in total

Review 1.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

Review 2.  Heat-shock proteins as regulators of apoptosis.

Authors:  Shinichi Takayama; John C Reed; Sachiko Homma
Journal:  Oncogene       Date:  2003-12-08       Impact factor: 9.867

Review 3.  Heat shock proteins: their role in urological tumors.

Authors:  Thierry Lebret; R William G Watson; John M Fitzpatrick
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

4.  The potential role of HSP70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer.

Authors:  F F Liu; N Miller; W Levin; B Zanke; B Cooper; M Henry; M D Sherar; M Pintilie; J W Hunt; R P Hill
Journal:  Int J Hyperthermia       Date:  1996 Mar-Apr       Impact factor: 3.914

5.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

6.  Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death.

Authors:  P Mehlen; K Schulze-Osthoff; A P Arrigo
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

7.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

Review 8.  Colon cancer: genomics and apoptotic events.

Authors:  Charleen Rupnarain; Zodwa Dlamini; Sarala Naicker; Kanti Bhoola
Journal:  Biol Chem       Date:  2004-06       Impact factor: 3.915

Review 9.  Thymidylate synthase and drug resistance.

Authors:  G J Peters; C L van der Wilt; B van Triest; G Codacci-Pisanelli; P G Johnston; C J van Groeningen; H M Pinedo
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

10.  Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells.

Authors:  M Jäättelä
Journal:  Int J Cancer       Date:  1995-03-03       Impact factor: 7.396

View more
  12 in total

1.  Expression of HSP27, HSP72 and MRP proteins in in vitro co-culture of colon tumour cell spheroids with normal cells after incubation with rhTGF- beta1 and/or CPT-11.

Authors:  Roman Paduch; Joanna Jakubowicz-Gil; Martyna Kandefer-Szerszen
Journal:  J Biosci       Date:  2009-12       Impact factor: 1.826

2.  PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage.

Authors:  B H Huang; J L Zhuo; C H W Leung; G D Lu; J J Liu; C T Yap; S C Hooi
Journal:  Cell Death Dis       Date:  2012-12-13       Impact factor: 8.469

3.  Pseudomonas aeruginosa exotoxin A reduces chemoresistance of oral squamous carcinoma cell via inhibition of heat shock proteins 70 (HSP70).

Authors:  Sang Rye Park; Kyoung Duk Lee; Uk Kyu Kim; Young Gi Gil; Kyu Seon Oh; Bong Soo Park; Gyoo Cheon Kim
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 3.052

4.  Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate.

Authors:  Verena Natalie Schreier; Lilla Pethő; Erika Orbán; Andreas Marquardt; Brindusa Alina Petre; Gábor Mező; Marilena Manea
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

5.  Geranylgeranylacetone attenuates cisplatin-induced reductions in cell viability by suppressing the elevation of intracellular p53 content without heat shock protein induction.

Authors:  Motofusa Hasegawa; Kazuhiro Ishiguro; Takafumi Ando; Hidemi Goto
Journal:  Nagoya J Med Sci       Date:  2012-02       Impact factor: 1.131

6.  Re-examining HSPC1 inhibitors.

Authors:  Sheah Lin Lee; Nina Claire Dempsey-Hibbert; Dale Vimalachandran; Terence David Wardle; Paul A Sutton; John H H Williams
Journal:  Cell Stress Chaperones       Date:  2017-03-02       Impact factor: 3.667

7.  Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapy.

Authors:  Yu-Shan Wang; Shih-Jen Liu; Su-Chen Huang; Chao-Chun Chang; Yi-Chun Huang; Weng-Lam Fong; Mau-Shin Chi; Kwan-Hwa Chi
Journal:  Front Oncol       Date:  2012-10-29       Impact factor: 6.244

8.  The Cytotoxicity of Kahweol in HT-29 Human Colorectal Cancer Cells Is Mediated by Apoptosis and Suppression of Heat Shock Protein 70 Expression.

Authors:  Dong Wook Choi; Man Sup Lim; Jae Won Lee; Wanjoo Chun; Sang Hyuk Lee; Yang Hoon Nam; Jin Myung Park; Dae Hee Choi; Chang Don Kang; Sung Joon Lee; Sung Chul Park
Journal:  Biomol Ther (Seoul)       Date:  2015-03-01       Impact factor: 4.634

9.  New insights into the RNA-based mechanism of action of the anticancer drug 5'-fluorouracil in eukaryotic cells.

Authors:  Laura Mojardín; Javier Botet; Luis Quintales; Sergio Moreno; Margarita Salas
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

10.  Expression of P33(ING1b) Protein in Colorectal Cancer.

Authors:  Somayeh Fallahnezhad; Mehdi Nikbakht; Saeed Shokri
Journal:  Middle East J Dig Dis       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.